Mariela del Carmen Carrica
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mariela del Carmen Carrica has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Maria Eugenia Rodriguez
CINDEFI (UNLP CONICET La Plata), Facultad de Ciencias Exactas Universidad Nacional de La Plata La Plata Argentina
4 shared publications - Juan Pablo Gorgojo
CINDEFI (UNLP CONICET La Plata), Facultad de Ciencias Exactas Universidad Nacional de La Plata La Plata Argentina
2 shared publications - Yanina Lamberti
CINDEFI (UNLP − CONICET), Facultad de Ciencias Exactas
2 shared publications - Carlos Manuel Baroli
CINDEFI (UNLP CONICET La Plata), Facultad de Ciencias Exactas Universidad Nacional de La Plata La Plata Argentina
1 shared publication Christian Hentschker
Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics
1 shared publicationHugo Alberto Valdez
CINDEFI (UNLP CONICET La Plata), Facultad de Ciencias Exactas, Universidad Nacional de La Plata, La Plata, Argentina
1 shared publication
Latest Publications
- 6 October 2026
- Published by Wiley in Microbiology and Immunology
Bordetella parapertussis Evades Neutrophil‐Mediated Killing by Failing to Trigger Innate Activation Even After IFN‐γ Priming
B. parapertussis is one of the etiologic agents of whooping cough and its incidence has increased following the COVID‐19 pandemic. Since current pertussis vaccines fail to induce protection against B. parapertussis , the course of infection critically relies on the innate immune response. However, in the absence of opsonic antibodies, B. parapertussis fails to activate resting neutrophils, thereby preventing bactericidal responses. We here investigated whether neutrophil priming with gamma‐interferon (IFN‐γ), the main proinflammatory cytokine present during infection, changes this outcome. We observed that IFN‐γ‐ priming of neutrophils did not enhance extracellular nor intracellular bactericidal mechanisms against B. parapertussi s. Human neutrophils remain basically unresponsive to this pathogen despite IFN‐γ priming, and this lack of activation proved independent of adenylate cyclase toxin (CyaA), the immunomodulatory toxin produced by B. parapertussis . Collectively, our findings demonstrate that B. parapertussis does not trigger neutrophil activation, irrespective of the inflammatory context. This ability to evade a key arm of the innate immune response likely constitutes a critical pathogenic trait that, particularly in the absence of cross‐protection conferred by current pertussis vaccines, underlies persistent infections and the continued circulation of the pathogen.
- 6 October 2026
- Published by Wiley in Microbiology and Immunology
Bordetella parapertussis Evades Neutrophil‐Mediated Killing by Failing to Trigger Innate Activation Even After IFN‐γ Priming
B. parapertussis is one of the etiologic agents of whooping cough and its incidence has increased following the COVID‐19 pandemic. Since current pertussis vaccines fail to induce protection against B. parapertussis , the course of infection critically relies on the innate immune response. However, in the absence of opsonic antibodies, B. parapertussis fails to activate resting neutrophils, thereby preventing bactericidal responses. We here investigated whether neutrophil priming with gamma‐interferon (IFN‐γ), the main proinflammatory cytokine present during infection, changes this outcome. We observed that IFN‐γ‐ priming of neutrophils did not enhance extracellular nor intracellular bactericidal mechanisms against B. parapertussi s. Human neutrophils remain basically unresponsive to this pathogen despite IFN‐γ priming, and this lack of activation proved independent of adenylate cyclase toxin (CyaA), the immunomodulatory toxin produced by B. parapertussis . Collectively, our findings demonstrate that B. parapertussis does not trigger neutrophil activation, irrespective of the inflammatory context. This ability to evade a key arm of the innate immune response likely constitutes a critical pathogenic trait that, particularly in the absence of cross‐protection conferred by current pertussis vaccines, underlies persistent infections and the continued circulation of the pathogen.
- 20 September 2025
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 24 (10) , 5254-5265
Proteomic Profiling Reveals RisR as a Novel Regulatory Element in the Virulence Network of Bordetella pertussis
Bordetella pertussis, the causative agent of whooping cough, regulates its virulence through the BvgAS two-component system, which controls the transition between virulent (Bvg+) and avirulent (Bvg-) phases. In the virulent phase, virulence-activated genes (vags) are expressed, while in the avirulent phase, these are repressed. Virulence-repressed genes (vrgs) are induced under the control of the response regulator RisA. Phosphorylation of RisA by the nonoperonic kinase RisK is essential for vrgs expression. Adjacent to risK lies risR, a gene encoding a putative response regulator, whose function remained unexplored. To investigate the RisR's role in B. pertussis biology, we performed comparative proteomic analyses between wild-type and an isogenic risR-deficient strain, grown under both virulent and avirulent conditions. Our data show that RisR modulates the abundance of proteins encoded by vags and vrgs, suggesting a previously unrecognized interplay between RisR and the BvgAS-RisAK regulatory network. Moreover, RisR regulates the abundance of proteins important for bacterial fitness, including those involved in iron acquisition and intracellular adaptation. Functional assays further support the role of RisR in promoting intracellular survival. This study provides the first proteome-wide characterization of the RisR regulon and identifies it as a novel regulator of B. pertussis virulence and adaptation.
- 20 September 2025
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 24 (10) , 5254-5265
Proteomic Profiling Reveals RisR as a Novel Regulatory Element in the Virulence Network of Bordetella pertussis
Bordetella pertussis, the causative agent of whooping cough, regulates its virulence through the BvgAS two-component system, which controls the transition between virulent (Bvg+) and avirulent (Bvg-) phases. In the virulent phase, virulence-activated genes (vags) are expressed, while in the avirulent phase, these are repressed. Virulence-repressed genes (vrgs) are induced under the control of the response regulator RisA. Phosphorylation of RisA by the nonoperonic kinase RisK is essential for vrgs expression. Adjacent to risK lies risR, a gene encoding a putative response regulator, whose function remained unexplored. To investigate the RisR's role in B. pertussis biology, we performed comparative proteomic analyses between wild-type and an isogenic risR-deficient strain, grown under both virulent and avirulent conditions. Our data show that RisR modulates the abundance of proteins encoded by vags and vrgs, suggesting a previously unrecognized interplay between RisR and the BvgAS-RisAK regulatory network. Moreover, RisR regulates the abundance of proteins important for bacterial fitness, including those involved in iron acquisition and intracellular adaptation. Functional assays further support the role of RisR in promoting intracellular survival. This study provides the first proteome-wide characterization of the RisR regulon and identifies it as a novel regulator of B. pertussis virulence and adaptation.
- 17 June 2024
- Published by Elsevier in Microbial Pathogenesis
- Vol. 193, 106754
BPP0974 is a Bordetella parapertussis adhesin expressed in the avirulent phase, implicated in biofilm formation and intracellular survival
- 17 June 2024
- Published by Elsevier in Microbial Pathogenesis
- Vol. 193, 106754
BPP0974 is a Bordetella parapertussis adhesin expressed in the avirulent phase, implicated in biofilm formation and intracellular survival
- 29 November 2022
- Published by Elsevier in Microbial Pathogenesis
- Vol. 174, 105898
Bordetella parapertussis adenylate cyclase toxin promotes the bacterial survival to the encounter with macrophages
- 29 November 2022
- Published by Elsevier in Microbial Pathogenesis
- Vol. 174, 105898
Bordetella parapertussis adenylate cyclase toxin promotes the bacterial survival to the encounter with macrophages